1-11 of 11
Edmund A. Rossi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A32: Pretargeted immunoPET of CEA-expressing in intraperitoneal human colonic tumor xenografts in nude mice

Rafke Schoffelen, Robert M. Sharkey, Gerben M. Franssen, David M. Goldenberg, William J. McBride, Edmund A. Rossi, Chien-Hsing Chang, Peter Laverman, Winette T.A. Graaf, Wim J.G. Oyen, Otto C. Boerman
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (7_Supplement): A32.
https://doi.org/10.1158/1078-0432.TCME10-A32
Published: 02 February 2016
View article titled, Abstract A32: Pretargeted immunoPET of CEA-expressing in intraperitoneal human colonic tumor xenografts in nude mice
Journal Articles

Enhanced Delivery of SN-38 to Human Tumor Xenografts with an Anti-Trop-2–SN-38 Antibody Conjugate (Sacituzumab Govitecan)

Robert M. Sharkey, William J. McBride, Thomas M. Cardillo, Serengulam V. Govindan, Yang Wang, Edmund A. Rossi, Chien-Hsing Chang, David M. Goldenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (22): 5131–5138.
https://doi.org/10.1158/1078-0432.CCR-15-0670
Published: 12 November 2015
View article titled, Enhanced Delivery of SN-38 to Human Tumor Xenografts with an Anti-Trop-2–SN-38 Antibody Conjugate (Sacituzumab Govitecan)
Open the PDF for Enhanced Delivery of SN-38 to Human Tumor Xenografts with an Anti-Trop-2–SN-38 Antibody Conjugate (Sacituzumab Govitecan) in another window
Includes: Supplementary data
Journal Articles

The Dock and Lock Method: A Novel Platform Technology for Building Multivalent, Multifunctional Structures of Defined Composition with Retained Bioactivity

Chien-Hsing Chang, Edmund A. Rossi, David M. Goldenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (18): 5586s–5591s.
https://doi.org/10.1158/1078-0432.CCR-07-1217
Published: 17 September 2007
View article titled, The Dock and Lock Method: A Novel Platform Technology for Building Multivalent, Multifunctional Structures of Defined Composition with Retained Bioactivity
Open the PDF for The Dock and Lock Method: A Novel Platform Technology for Building Multivalent, Multifunctional Structures of Defined Composition with Retained Bioactivity in another window
Journal Articles

Bispecific Antibody Pretargeting of Radionuclides for Immuno–Single-Photon Emission Computed Tomography and Immuno–Positron Emission Tomography Molecular Imaging: An Update

Robert M. Sharkey, Habibe Karacay, William J. McBride, Edmund A. Rossi, Chien-Hsing Chang, David M. Goldenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (18): 5577s–5585s.
https://doi.org/10.1158/1078-0432.CCR-07-1087
Published: 17 September 2007
View article titled, Bispecific Antibody Pretargeting of Radionuclides for Immuno–Single-Photon Emission Computed Tomography and Immuno–Positron Emission Tomography Molecular Imaging: An Update
Open the PDF for Bispecific Antibody Pretargeting of Radionuclides for Immuno–Single-Photon Emission Computed Tomography and Immuno–Positron Emission Tomography Molecular Imaging: An Update in another window
Journal Articles

A Divalent Hapten-Peptide Induces Apoptosis in Human Non–Hodgkin Lymphoma Cell Lines Targeted by Anti-CD20 × Anti-Hapten Bispecific Antibodies

Pierre-Yves Brard, Habibe Karacay, Rhona Stein, Robert M. Sharkey, M. Jules Mattes, Chien-Hsing Chang, Edmund A. Rossi, William J. McBride, David M. Goldenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (18): 5564s–5571s.
https://doi.org/10.1158/1078-0432.CCR-07-1204
Published: 17 September 2007
View article titled, A Divalent Hapten-Peptide Induces Apoptosis in Human Non–Hodgkin Lymphoma Cell Lines Targeted by Anti-CD20 × Anti-Hapten Bispecific Antibodies
Open the PDF for A Divalent Hapten-Peptide Induces Apoptosis in Human Non–Hodgkin Lymphoma Cell Lines Targeted by Anti-CD20 × Anti-Hapten Bispecific Antibodies in another window
Journal Articles

Bispecific Antibody Pretargeting of Tumor Neovasculature for Improved Systemic Radiotherapy of Solid Tumors

Dieter Moosmayer, Dietmar Berndorff, Chien-Hsing Chang, Robert M. Sharkey, Axel Rother, Sandra Borkowski, Edmund A. Rossi, William J. McBride, Thomas M. Cardillo, David M. Goldenberg, Ludger M. Dinkelborg
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (18): 5587–5595.
https://doi.org/10.1158/1078-0432.CCR-06-0210
Published: 25 September 2006
View article titled, Bispecific Antibody Pretargeting of Tumor Neovasculature for Improved Systemic Radiotherapy of Solid Tumors
Open the PDF for Bispecific Antibody Pretargeting of Tumor Neovasculature for Improved Systemic Radiotherapy of Solid Tumors in another window
Journal Articles

Therapeutic Advantage of Pretargeted Radioimmunotherapy Using a Recombinant Bispecific Antibody in a Human Colon Cancer Xenograft

Habibe Karacay, Pierre-Yves Brard, Robert M. Sharkey, Chien-Hsing Chang, Edmund A. Rossi, William J. McBride, Dan R. Ragland, Ivan D. Horak, David M. Goldenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (21): 7879–7885.
https://doi.org/10.1158/1078-0432.CCR-05-1246
Published: 08 November 2005
View article titled, Therapeutic Advantage of Pretargeted Radioimmunotherapy Using a Recombinant Bispecific Antibody in a Human Colon Cancer Xenograft
Open the PDF for Therapeutic Advantage of Pretargeted Radioimmunotherapy Using a Recombinant Bispecific Antibody in a Human Colon Cancer Xenograft in another window
Journal Articles

Pretargeting of Carcinoembryonic Antigen–Expressing Cancers with a Trivalent Bispecific Fusion Protein Produced in Myeloma Cells

Edmund A. Rossi, Chien-Hsing Chang, Michele J. Losman, Robert M. Sharkey, Habibe Karacay, William McBride, Thomas M. Cardillo, Hans J. Hansen, Zhengxing Qu, Ivan D. Horak, David M. Goldenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (19): 7122s–7129s.
https://doi.org/10.1158/1078-0432.CCR-1004-0020
Published: 03 October 2005
View article titled, Pretargeting of Carcinoembryonic Antigen–Expressing Cancers with a Trivalent Bispecific Fusion Protein Produced in Myeloma Cells
Open the PDF for Pretargeting of Carcinoembryonic Antigen–Expressing Cancers with a Trivalent Bispecific Fusion Protein Produced in Myeloma Cells in another window
Journal Articles

Improving the Delivery of Radionuclides for Imaging and Therapy of Cancer Using Pretargeting Methods

Robert M. Sharkey, Habibe Karacay, Thomas M. Cardillo, Chien-Hsing Chang, William J. McBride, Edmund A. Rossi, Ivan D. Horak, David M. Goldenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (19): 7109s–7121s.
https://doi.org/10.1158/1078-0432.CCR-1004-0009
Published: 03 October 2005
View article titled, Improving the Delivery of Radionuclides for Imaging and Therapy of Cancer Using Pretargeting Methods
Open the PDF for Improving the Delivery of Radionuclides for Imaging and Therapy of Cancer Using Pretargeting Methods in another window
Journal Articles

Optimizing Bispecific Antibody Pretargeting for Use in Radioimmunotherapy

Robert M. Sharkey, Habibe Karacay, Heidi Richel, William J. McBride, Edmund A. Rossi, Ken Chang, Dion Yeldell, Gary L. Griffiths, Hans J. Hansen, David M. Goldenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (10): 3897s–3913s.
Published: 01 September 2003
View article titled, Optimizing Bispecific Antibody Pretargeting for Use in Radioimmunotherapy
Open the PDF for Optimizing Bispecific Antibody Pretargeting for Use in Radioimmunotherapy in another window
Journal Articles

Development of New Multivalent-bispecific Agents for Pretargeting Tumor Localization and Therapy

Edmund A. Rossi, Robert M. Sharkey, William McBride, Habibe Karacay, Li Zeng, Hans J. Hansen, David M. Goldenberg, Chien-Hsing Chang
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (10): 3886s–3896s.
Published: 01 September 2003
View article titled, Development of New Multivalent-bispecific Agents for Pretargeting Tumor Localization and Therapy
Open the PDF for Development of New Multivalent-bispecific Agents for Pretargeting Tumor Localization and Therapy in another window